Cargando…

OR34-2 SREBP1 Drives KRT80-Dependent Cytoskeletal Changes and Invasive Behaviour in Endocrine-Resistant ERα Breast Cancer

About one third of oestrogen receptor alpha breast cancer (ERα BC) patients progress to invasive metastatic disease despite targeted endocrine therapies(1). Our previous study showed how breast cancer cells developing resistance to aromatase inhibitors (AI) endogenously trigger cholesterol biosynthe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perone, Ylenia, Rodríguez Meira, Alba, Farruggia, Aaron, Győrffy, Balázs, Ion, Charlotte, Pruneri, Giancarlo, Lim, Adrian, Calvo, Fernando, Magnani, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Tumor Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6555066/ http://dx.doi.org/10.1210/js.2019-OR34-2

Ejemplares similares

SREBP1 drives Keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

Author Correction: SREBP1 drives keratin-80-dependent cytoskeletal changes and invasive behavior in endocrine-resistant ERα breast cancer
por: Perone, Ylenia, et al.
Publicado: (2019)

SAT-119 Targeting Glutamate Metabolism and Signaling in ER+, Endocrine Therapy-Resistant Breast Cancer
por: Olukoya, Ayodeji O, et al.
Publicado: (2020)

OR16-5 Riluzole suppresses growth and enhances response to endocrine therapy in ER+ breast cancer
por: Bahnassy, Shaymaa, et al.
Publicado: (2022)

Characters of KRT80 and its roles in neoplasms diseases
por: Wei, Xin‐Yuan, et al.
Publicado: (2023)

SAT-144 Cooperative Mechanism of SREBP-Dependent Cholesterol Synthesis Pathway and P53 on Malignant Formation in Breast Cancer
por: Nakayama, Akitoshi, et al.
Publicado: (2020)

Mechanism of Mutant p53 Using Three-Dimensional Culture on Breast Cancer Malignant Phenotype via SREBP-Dependent Cholesterol Synthesis Pathway
por: Nakayama, Akitoshi, et al.
Publicado: (2021)

Recurrent Pheochromocytoma, as Component of Multiple Endocrine Neoplasia
por: Dominguez, Hydelene Beray, et al.
Publicado: (2021)

Small interfering RNA-mediated knockdown of KRT80 suppresses colorectal cancer proliferation
por: Lin, Jiatian, et al.
Publicado: (2020)

Strategic Impact of a New Academic Endocrine Surgery Program
por: Wiseman, James E., et al.
Publicado: (2011)

A Rare Presentation of Multiple Endocrine Neoplasia Type 1
por: Pradeep, Pallavi, et al.
Publicado: (2021)

Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy
por: Hong, Sung Pil, et al.
Publicado: (2019)

THU559 3D Immuno-smFISH Reveals ER-responsive Cells At The Single-cell Level In ER(+) Breast Cancer
por: Kammel, Laura G, et al.
Publicado: (2023)

KRAS driven expression signature has prognostic power superior to mutation status in non‐small cell lung cancer
por: Nagy, Ádám, et al.
Publicado: (2016)

MON-LB053 Involvement of Stromal Age in Breasts Cancer Endocrine Response
por: Cavalier, Maryn, et al.
Publicado: (2019)

SAT-LB310 A Mysterious Multiple Endocrine Neoplasia (MEN) Like Syndrome
por: Soe, Myat Han, et al.
Publicado: (2020)

MON-906 MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A: Familiar Case Report
por: Sousa, Barbara K P, et al.
Publicado: (2020)

MON-922 Multiple Endocrine Neoplasia Type 1- A Clarion Call for Clarity
por: Hashmi, Hiba, et al.
Publicado: (2020)

Thymoma and Not Just Thymic Carcinoid Can Be Associated With Multiple Endocrine Neoplasia Type 1
por: Graf, Akua, et al.
Publicado: (2021)

Acquired CYP19A1 amplification is an early specific mechanism of aromatase inhibitor resistance in ERα metastatic breast cancer
por: Magnani, Luca, et al.
Publicado: (2017)

Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
por: Nguyen, Van T. M., et al.
Publicado: (2015)

OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer
por: Ouyang, Siwen, et al.
Publicado: (2022)

Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma
por: Palkó, Enikő, et al.
Publicado: (2018)

SUN-LB26 Radioligand Theranostics of Endocrine-Related Cancers; A New, Revolutionary Approach
por: Harris, Alan G, et al.
Publicado: (2020)

SUN-912 The Rare Men of Mississippi Complications in the Diagnosis of Multiple Endocrine Neoplasia Type 1
por: Rashid, Hytham, et al.
Publicado: (2020)

SUN-127 Diagnostic Challenges Associated with the Rising Incidence of Endocrine Toxicity in the Era of Combination Immunotherapy
por: Galligan, Anna, et al.
Publicado: (2020)

ODP538 A Case of Multiple Endocrine Neoplasia Type 2A with Malignant Paraganglioma
por: Ozawa, Atsushi, et al.
Publicado: (2022)

ODP647 Nuclear ERα and NAMPT Crosstalk in Metastatic Breast Tumors
por: Mogol, Ayca, et al.
Publicado: (2022)

The Adhesion G-Protein-Coupled Receptor GPR115/ADGRF4 Regulates Epidermal Differentiation and Associates with Cytoskeletal KRT1
por: Winkler, Romy, et al.
Publicado: (2022)

SUN-341 A Natural History Study for Rare Tumors: An Avenue for Discovering and Understanding Endocrine Cancers
por: Thomas, BJ, et al.
Publicado: (2019)

Papillary Thyroid Carcinoma and Cushing’s Disease: A Rare Association With Multiple Endocrine Neoplasia Type 1
por: Benevides, Léo Nunes, et al.
Publicado: (2021)

RF07 | PSUN366 An Uncommon Path Leading to Diagnosis of Multiple Endocrine Neoplasia 2A
por: Gokul, Sagarika, et al.
Publicado: (2022)

THU548 The Role Of Sirtuin 3 In Endocrine Therapy Resistant Breast Cancer Cells Response To Fulvestrant
por: de Oliveira, Karla Andrade, et al.
Publicado: (2023)

ODP539 AIPB is a Biomarker for ER+/PR+/Her2- Breast Cancers
por: Cubbedge, Chandler, et al.
Publicado: (2022)

Enhancer mapping uncovers phenotypic heterogeneity and evolution in patients with luminal breast cancer
por: Patten, Darren K., et al.
Publicado: (2018)

Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion
por: Nguyen, Van T. M., et al.
Publicado: (2019)

MON-321 Metastatic Melanoma with Unknown Primary Site in a Patient with Multiple Endocrine Neoplasia Type 1
por: Kamilaris, Crystal, et al.
Publicado: (2019)

SAT-LB060 Clinical Presentation and Management of Primary Ovarian Carcinoids in Multiple Endocrine Neoplasia Type 1
por: Jhawar, Sakshi, et al.
Publicado: (2019)

OR34-1 Regulation of Breast Cancer Stem Cells by Nuclear Receptor Co-Regulatory Proteins
por: Ostrander, Julie, et al.
Publicado: (2019)

Correction: OTUB2 regulates KRT80 stability via deubiquitination and promotes tumour proliferation in gastric cancer
por: Ouyang, Siwen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fisogvdpkbt7ad257rqfej1i21